FBIO - Journey Medical announces U.S. FDA acceptance of NDA for its rosacea treatment
2024-03-19 07:17:00 ET
Update Mar. 19, 2023, 07.17 AM EST: Adds details about Fortress Biotech
More on Journey Medical
- Journey Medical submits NDA for DFD-29 for rosacea
- Journey Medical secures credit facility for up to $20M
- Seeking Alpha’s Quant Rating on Journey Medical
- Historical earnings data for Journey Medical
- Financial information for Journey Medical